A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases
Clinical trial NCT03800472 · COMPLETED
Trial details
- NCT number
- NCT03800472
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2020-03-10
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.